SKI Market

A+| A| A-|

Indian Indices

Sensex

73,583.22 -1,690.23
( -2.25%)

Global Indices

Nasdaq

45,202.56 -778.56
(-1.69%)

Dow Jones

6,394.42 -103.74
(-1.60%)

Hang Seng

53,412.46 -191.19
(-0.36%)

Nikkei 225

9,959.27 -12.90
(-0.13%)

Forex

USD-INR

94.09 0.23
(0.24%)

EUR-INR

108.64 -0.12
(-0.11%)

GBP-INR

125.57 -0.09
(-0.07%)

JPY-INR

0.59 0.00
(-0.07%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Gufic BioSciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

509079

INE742B01025

62.6776943

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GUFICBIO

55.86

2823.45

EPS(TTM)

Face Value()

Div & Yield %

5.04

0.04

Back

Dwarikesh Sugar Industries reports standalone net loss of Rs 32.62 crore in the September 2025 quarter

Oct 31,2025

Net Loss of Dwarikesh Sugar Industries reported to Rs 32.62 crore in the quarter ended September 2025 as against net loss of Rs 24.00 crore during the previous quarter ended September 2024. Sales declined 0.05% to Rs 245.93 crore in the quarter ended September 2025 as against Rs 246.06 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	245.93	246.06	0
OPM %	-16.77	-9.35	-
PBDT	-40.70	-23.72	-72
PBT	-52.94	-36.04	-47
NP	-32.62	-24.00	-36

73,583.22 -1,690.23 ( -2.25%)

45,202.56 -778.56 (-1.69%)

6,394.42 -103.74 (-1.60%)

53,412.46 -191.19 (-0.36%)

9,959.27 -12.90 (-0.13%)

94.09 0.23 (0.24%)

108.64 -0.12 (-0.11%)

125.57 -0.09 (-0.07%)

0.59 0.00 (-0.07%)